Clinical Trial Update: Safety and Immunogenicity Study of Influenza Vaccines in HIV-infected and HIV-uninfected Pregnant Women in Western Kenya [Phase 2, Phase 3]

View source ↗

Summary

A CDC-sponsored Phase 2/3 trial evaluating the safety and immunogenicity of influenza vaccines in HIV-infected and HIV-uninfected pregnant women in Western Keny…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Influenza vaccine (influenza vaccine)

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: Influenza, Human, HIV | Phase 2, Phase 3 | Status: WITHDRAWN